REVELATION BIOSCIENCES INC (REVB:NASDAQ)
$1.16 0 (0%)
Analysed REVELATION BIOSCIENCES INC (REVB:NASDAQ) News Sources
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
06-04-2026
yahoo.com
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
30-03-2026
yahoo.com
REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
24-03-2026
yahoo.com
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
19-03-2026
yahoo.com
REVB 2026 Starts in Positive Fashion
27-02-2026
yahoo.com
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
26-02-2026
yahoo.com
REVB Comes to Agreement with FDA
29-01-2026
yahoo.com
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
26-01-2026
yahoo.com
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
23-01-2026
yahoo.com
BC-Most Active Stocks
23-01-2026
yahoo.com
What is the current price of REVELATION BIOSCIENCES INC (REVB:NASDAQ)?
The current price of REVELATION BIOSCIENCES INC (REVB:NASDAQ) is $1.16.
REVELATION BIOSCIENCES INC (REVB:NASDAQ) absolute price change since previous trading day?
The absolute price change of REVELATION BIOSCIENCES INC (REVB:NASDAQ) since the previous trading day is $0.
REVELATION BIOSCIENCES INC (REVB:NASDAQ) percentage price change since previous trading day?
The percentage price change of REVELATION BIOSCIENCES INC (REVB:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for REVELATION BIOSCIENCES INC (REVB:NASDAQ)?
The most recent average sentiment score for REVELATION BIOSCIENCES INC (REVB:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for REVELATION BIOSCIENCES INC (REVB:NASDAQ)?
The most recent sentiment for REVELATION BIOSCIENCES INC (REVB:NASDAQ) is .
SEC-8K** Filing Available For REVELATION BIOSCIENCES INC (REVB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.